|
Resverlogix In Active Discussions With The Kingdom of Morocco’s Ministry of Health For The Launch Of COVID-19 Clinical Studies With First-In-Class Dru
|
13
|
Resverlogix Corp.
|
Nov 01, 2021 08:34AM
|
|
Re: MERCK….
|
2
|
Resverlogix Corp.
|
Oct 04, 2021 10:50AM
|
|
Re: Management change at Resverlogix
|
4
|
Resverlogix Corp.
|
Jul 06, 2021 10:00AM
|
|
Re: Long Covid thought to affect half of Covid cases
|
4
|
Resverlogix Corp.
|
Jun 24, 2021 06:56PM
|
|
Re: One week later....
|
7
|
Resverlogix Corp.
|
May 21, 2021 10:05AM
|
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
2
|
Resverlogix Corp.
|
Apr 14, 2021 11:22PM
|
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
4
|
Resverlogix Corp.
|
Apr 14, 2021 10:51PM
|
|
Re: Warning: Long - Thoughts on Management
|
3
|
Resverlogix Corp.
|
Mar 26, 2021 03:24PM
|
|
Re: Warning: Long - Thoughts on Management
|
6
|
Resverlogix Corp.
|
Mar 25, 2021 06:36PM
|
|
Re: Warning: Long - Thoughts on Management
|
5
|
Resverlogix Corp.
|
Mar 24, 2021 07:36PM
|
|
Re: Apabetalone’s Beneficial Effects on COVID-19 Published in Prestigious Scientific Journal Cell
|
11
|
Resverlogix Corp.
|
Mar 18, 2021 10:33AM
|
|
Re: Resverlogix Announces Change in Fiscal Year-End to December 31
|
7
|
Resverlogix Corp.
|
Mar 14, 2021 07:08PM
|
|
Re: Resverlogix Announces Change in Fiscal Year-End to December 31
|
5
|
Resverlogix Corp.
|
Mar 14, 2021 11:02AM
|
|
Resverlogix Announces Change in Fiscal Year-End to December 31
|
1
|
Resverlogix Corp.
|
Mar 14, 2021 10:32AM
|
|
Re: Another variation
|
8
|
Resverlogix Corp.
|
Mar 04, 2021 09:40AM
|
|
Re: Another variation
|
9
|
Resverlogix Corp.
|
Mar 04, 2021 07:48AM
|
|
Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model
|
8
|
Resverlogix Corp.
|
Mar 03, 2021 11:44AM
|
|
Re: Summary of Proposed BETonMACE2 design and timelines
|
8
|
Resverlogix Corp.
|
Feb 12, 2021 03:52PM
|
|
Re: Finance
|
3
|
Resverlogix Corp.
|
Feb 06, 2021 10:45PM
|
|
Re: Rant time...
|
|
Resverlogix Corp.
|
Feb 05, 2021 11:32AM
|
